Attachment

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# Agreement Type Effective Date Expiration Dz External Parties *Lead Pl T-00627-2024 |Letter of Intent/MOU 11/15/2023] 11/15/2025] Rocketvax AG (c/o Swiss Rockets AG) John Beigel T-00655-2023 |Research Collaboration Agreement 3/14/2023] 3/19/2024] University of Wisconsin Mattia Bonsignori T-00659-2023 |Research Collaboration Agreement 3/2/2023} Children's National Medical Center (CNMC) [US] Jeffrey Cohen T-01216-2023 |Research Collaboration Agreement 6/1/2023} _10/1/2023}Leica Microsystems, Inc. [US] Ronald Germain T-01340-2023 |CTA - Clinical Trial Agreement 3/16/2023 Amplyx Pharmaceuticals, Inc. [US] Christa Zerbe T-01420-2023 |Gift 8/16/2021 Jim Miller Jonathan Lyons T-01815-2023 |Gift 6/7/2023} University of Cagliari Byron Caughey T-01865-2023 |Research Collaboration Agreement 5/12/2023} Walter Reed Army Institute of Reseach (WRAIR) Patrick Duffy T-01966-2023 |Research Collaboration Agreement 7/6/2023} 7/6/2028] Yale University Rachel Sparks T-02191-2023 |Research Collaboration Agreement 5/8/2023} 5/9/2025} Integral Molecular [US] Leah Katzelnick T-02327-2023 |Research Collaboration Agreement 11/1/2023] 11/1/2026] Vitarka Therapeutics Ltd Stephen Leppla Foundation for the National Institutes of Health, Inc. (FNIH), Jane Coffin Childs Memorial Fund for T-02339-2023 |Gift 10/5/2023] 10/5/2026] Medical Research Michael Grigg T-02353-2023 I Gift 5/24/2023] 9/30/2025 Bill & Melinda Gates Foundation (BMGF) Joshua Tan T-02608-2023 |Gift 7/11/2023 Infectious Diseases Society of America Patrick Duffy T-02916-2023 |Research Collaboration Agreement 6/20/2023] 6/20/2026] Yale University Byron Caughey T-03182-2023 |Research Collaboration Agreement 6/29/2023] 6/29/2026|Akagera Medicines, Inc Theodore Pierson T-03225-2023 |Research Collaboration Agreement 7/5/2023} 4/5/2024) The Scripps Research Institute (TSRI) Joshua Tan T-03609-2023 |Gift 8/16/2023} Jeffrey and Mary Smith Family Foundation Byron Caughey Moderna, Inc. (was Moderna Therapeutics, Inc., T-04145-2023 |Research Collaboration Agreement 9/22/2023) 6/2/2026]then ModernatX, Inc.) Paolo Lusso T-04588-2023 |Research Collaboration Agreement 11/7/2023] 11/7/2024] AstraZeneca Clifton Barry